α1‐Adrenergic Receptors Function Within Hetero‐Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C‐X‐C motif) Receptor 4 in Vascular Smooth Muscle Cells
Open Access
- 2 August 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 6 (8)
Abstract
Background: Recently, we provided evidence that α1‐adrenergic receptors (ARs) in vascular smooth muscle are regulated by chemokine (C‐X‐C motif) receptor (CXCR) 4 and atypical chemokine receptor 3 (ACKR3). While we showed thatCXCR4 controls α1‐ARsthrough formation of heteromeric receptor complexes in human vascular smooth muscle cells (hVSMCs), the molecular basis underlying cross‐talk betweenACKR3 and α1‐ARsis unknown.Methods and Results: We show thatACKR3 agonists inhibit inositol trisphosphate production inhVSMCson stimulation with phenylephrine. In proximity ligation assays and co‐immunoprecipitation experiments, we observed that recombinant and endogenousACKR3 form heteromeric complexes with α1A/B/D‐AR. While small interfering RNA knockdown ofACKR3 inhVSMCsreduced α1B/D‐AR:ACKR3,CXCR4:ACKR3, and α1B/D‐AR:CXCR4 complexes, small interfering RNA knockdown ofCXCR4 reduced α1B/D‐AR:ACKR3 heteromers. Phenylephrine‐induced inositol trisphosphate production fromhVSMCswas abolished afterACKR3 andCXCR4 small interfering RNA knockdown. Peptide analogs of transmembrane domains 2/4/7 ofACKR3 showed differential effects on heteromerization betweenACKR3, α1A/B/D‐AR,andCXCR4. While the transmembrane domain 2 peptide interfered with α1B/D‐AR:ACKR3 andCXCR4:ACKR3 heteromerization, it increased heteromerization betweenCXCR4 and α1A/B‐AR. The transmembrane domain 2 peptide inhibitedACKR3 but did not affect α1b‐ARin β‐arrestin recruitment assays. Furthermore, the transmembrane domain 2 peptide inhibited phenylephrine‐induced inositol trisphosphate production in hVSMCs and attenuated phenylephrine‐induced constriction of mesenteric arteries.Conclusions: α1‐ARsform hetero‐oligomeric complexes with theACKR3:CXCR4 heteromer, which is required for α1B/D‐ARfunction, and activation ofACKR3 negatively regulates α1‐ARs. G protein–coupled receptor hetero‐oligomerization is a dynamic process, which depends on the relative abundance of available receptor partners. Endogenous α1‐ARs function within a network of hetero‐oligomeric receptor complexes.Keywords
This publication has 34 references indexed in Scilit:
- New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth MuscleInternational Journal of Molecular Sciences, 2016
- Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesFrontiers in Immunology, 2015
- CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cellsJournal of Cell Science, 2010
- CXCR7 Functions as a Scavenger for CXCL12 and CXCL11PLOS ONE, 2010
- Formation and dissociation of M1muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single moleculesProceedings of the National Academy of Sciences, 2010
- How reliable are G-protein-coupled receptor antibodies?Naunyn-Schmiedeberg's Archives of Pharmacology, 2009
- Regulation of CXCR4 signalingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Direct observation of individual endogenous protein complexes in situ by proximity ligationNature Methods, 2006
- The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T LymphocytesJournal of Biological Chemistry, 2005
- Characterization of α1‐adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary arteryBritish Journal of Pharmacology, 1997